SCHEMBL7018367

SCHEMBL7018367

Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGR P09769 1/20 1.00
EPHA1 P21709 1/20 1.00
TXK P42681 1/20 1.00
FRK P42685 1/20 1.00
PTK6 Q13882 1/20 1.00
SRC P12931 17/20 0.88
ABL1 P00519 15/20 0.88
EGFR P00533 15/20 0.88
ABL2 P42684 13/20 0.88
LCK P06239 8/20 0.82
RET P07949 4/20 0.82
JAK2 O60674 3/20 0.82
INSR P06213 3/20 0.82
IGF1R P08069 3/20 0.82
KIT P10721 3/20 0.82
PDGFRA P16234 3/20 0.82
FGFR4 P22455 3/20 0.82
FGFR3 P22607 3/20 0.82
KDR P35968 3/20 0.82
ALK Q9UM73 3/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7021405 0.94 SRC (1.00) FGREPHA1TXKFRKPTK6
SCHEMBL12438228 0.90 ABL1 (1.00) FGREPHA1TXKFRKPTK6
SCHEMBL7020106 0.87 SRC (0.87) FGREPHA1TXKFRKPTK6
Hydrochloric Acid SCHEMBL7098308 0.85 SRC (0.85) FGREPHA1TXKFRKPTK6
SCHEMBL8098925 0.85 SRC (0.89) FGREPHA1TXKFRKPTK6
SCHEMBL14161976 0.84 ABL1 (0.77) FGREPHA1TXKFRKPTK6
SCHEMBL8108556 0.83 ABL1 (1.00) FGREPHA1TXKFRKPTK6
SCHEMBL8107017 0.81 ABL1 (0.83) FGREPHA1TXKFRKPTK6
SCHEMBL7013351 0.81 ABL1 (0.72) FGREPHA1TXKFRKPTK6
SCHEMBL7014326 0.81 ABL1 (0.86) FGREPHA1TXKFRKPTK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888353-B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2003-07-09 EP disclosed
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed